Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

4,432

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

March 31, 2008

Conditions
Haemophilus Influenzae Type bNeisseria Meningitidis
Interventions
BIOLOGICAL

GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014

3-dose intramuscular injection

BIOLOGICAL

ActHIB

3-dose intramuscular injection

BIOLOGICAL

Pediarix/Infanrix Penta

3-dose intramuscular injection

Trial Locations (63)

13210

GSK Investigational Site, Syracuse

13413

GSK Investigational Site, New Hartford

15090

GSK Investigational Site, Wexford

15202

GSK Investigational Site, Pittsburgh

15227

GSK Investigational Site, Pittsburgh

15236

GSK Investigational Site, Pittsburgh

15241

GSK Investigational Site, Pittsburgh

27609

GSK Investigational Site, Raleigh

28607

GSK Investigational Site, Deerfield

28721

GSK Investigational Site, Clyde

28779

GSK Investigational Site, Sylva

29406

GSK Investigational Site, Charleston

33324

GSK Investigational Site, Plantation

35235

GSK Investigational Site, Birmingham

35244

GSK Investigational Site, Birmingham

37660

GSK Investigational Site, Kingsport

37664

GSK Investigational Site, Kingsport

40004

GSK Investigational Site, Bardstown

40503

GSK Investigational Site, Lexington

44121

GSK Investigational Site, Cleveland

GSK Investigational Site, South Euclid

44718

GSK Investigational Site, Canton

44720

GSK Investigational Site, North Canton

49024

GSK Investigational Site, Portage

49120

GSK Investigational Site, Nies

49127

GSK Investigational Site, Stevensville

50263

GSK Investigational Site, Waukee

50266

GSK Investigational Site, West Desmoines

53792

GSK Investigational Site, Madison

54449

GSK Investigational Site, Marshfield

55108

GSK Investigational Site, Saint Paul

60453

GSK Investigational Site, Oak Lawn

71111

GSK Investigational Site, Bossier City

71913

GSK Investigational Site, Hot Springs

72015

GSK Investigational Site, Benton

72201

GSK Investigational Site, Little Rock

72205

GSK Investigational Site, Little Rock

72401

GSK Investigational Site, Jonesboro

72703

GSK Investigational Site, Fayetteville

77084

GSK Investigational Site, Houston

77450

GSK Investigational Site, Katy

80303

GSK Investigational Site, Boulder

80501

GSK Investigational Site, Longmont

84041

GSK Investigational Site, Layton

84057

GSK Investigational Site, Orem

84062

GSK Investigational Site, Pleasant Gorve

84088

GSK Investigational Site, West Jordan

84095

GSK Investigational Site, South Jordan

84109

GSK Investigational Site, Salt Lake City

84405

GSK Investigational Site, Ogden

89104

GSK Investigational Site, Las Vegas

91790

GSK Investigational Site, West Covina

92708

GSK Investigational Site, Fountain Valley

93637

GSK Investigational Site, Madera

93710

GSK Investigational Site, Fresno

93726

GSK Investigational Site, Fresno

93901

GSK Investigational Site, Slinas

208 463 3126

GSK Investigational Site, Nampa

02111

GSK Investigational Site, Boston

02130

GSK Investigational Site, Jamaica Plain

44308-1062

GSK Investigational Site, Akron

04530

GSK Investigational Site, Mexico City

06720

GSK Investigational Site, Mexico City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00345579 - Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age | Biotech Hunter | Biotech Hunter